Company Filing History:
Years Active: 2017-2020
Title: The Innovative Contributions of Tomohide Yamazaki
Introduction: Tomohide Yamazaki is a distinguished inventor based in Tokyo, Japan. With a total of four patents to his name, he has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work demonstrates both creativity and dedication to advancing medical science.
Latest Patents: Yamazaki's latest inventions include two notable patents. The first patent involves polynucleotides encoding anti-human receptor-type protein tyrosine phosphatase sigma antibodies. This invention focuses on a monoclonal antibody that binds to an extracellular domain of the human receptor-type protein tyrosine phosphatase sigma (human PTPRS), or a fragment containing an antigen-binding region thereof. The second patent addresses methods of using anti-phospholipase D4 antibodies, which also involves a monoclonal antibody that binds to a phospholipase D4 (PLD4) protein, or a fragment containing an antigen-binding region thereof. Both patents highlight his expertise in antibody technology, showing potential therapeutic applications.
Career Highlights: Tomohide Yamazaki is currently employed at Sbi Biotech Co., Ltd., where he continues to push the boundaries of innovation in biotechnology. His work not only contributes to the company's portfolio but also furthers scientific understanding in the therapeutic use of monoclonal antibodies.
Collaborations: Throughout his career, Yamazaki has collaborated with talented individuals, including his coworkers Minkwon Cho and Mayuki Endo. Their collaborative efforts are essential in driving research and development forward, showcasing the power of teamwork in the innovation landscape.
Conclusion: Tomohide Yamazaki represents the spirit of innovation in biotechnology. His patents and collaborations reflect a commitment to improving human health and advancing scientific knowledge. As a leading inventor in his field, his contributions will likely continue to influence future developments in medical therapies.